Expression of fibroblast growth factor-1 (FGF-1), FGF-2 and FGF receptor-1 in a human salivary-gland adenocarcinoma cell line: Evidence of autocrine growth

International Journal of Cancer

Volumn 65, Issue 5, 1996, Pages 650-657

  Myoken, Yoshiko ^a   Myoken, Yoshinari ^b   Okamoto, Tetsuji ^a   Kan, Mikio ^c   Mckeehan, Wallace L ^c   Sato, J Denry ^d   Takada, Kazuaki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b Hiroshima Red Cross Atom Bomb S ^*  (Japan)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^d Adirondack Biomedical Research Institute Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR;

ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SALIVARY GLAND CARCINOMA;

ADENOCARCINOMA; AMINO ACID SEQUENCE; BASE SEQUENCE; CELL DIVISION; DNA PRIMERS; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES; HUMANS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES, ANTISENSE; RECEPTORS, FIBROBLAST GROWTH FACTOR; RNA, MESSENGER; RNA, NEOPLASM; SALIVARY GLAND NEOPLASMS;

EID: 0029879129     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960301)65:5<650::AID-IJC15>3.0.CO;2-B     Document Type: Article

References (35)

1. ABRAHAM, J.A., WHANG, J.L., TUMOLO, A., MERGIA, A., FRIEDMAN, J., GOSPODAROWICZ, D. and FIDDES, J.C., Human basic fibroblast growth factor: nucleotide sequence and genomic organization. EMBO J., 5, 2523-2528 (1986).
2. AZUMA, M., YOSHIDA, H., KAWAMMATA, H., YANAGAWA, T., FURUMOTO, N. and SATO, M., Cellular proliferation and ras oncogene of p21 21,000 expression in relation to the intracellular cyclic adenosine 3′: 5′-monophosphate levels of a human salivary gland adenocarcinoma cell line in culture. Cancer Res., 48, 2898-2903 (1988).
3. BURGESS, W.H. and MACIAG, T., The heparin-binding (fibroblast) growth factor family of proteins. Ann. Rev. Biochem., 58, 575-606 (1989).
4. CHELLAIAH, A.T., MCEWEN, D.G., WERNER, S., XU, J. and ORNITZ, D.M., Fibroblast growth factor receptor (FGFR)3. Alternative splicing in immunogloblin-like domain III creates a receptor highly specific for acidic FGF/FGF-1. J. biol. Chem., 269, 11620-11627 (1994).
5. EGUCHI, J., NOMATA, K., KANDA., S., IGAUA, T., TAIDE, M., KOGA, S., MATSUYA, F., KANETAKE, H. and SAITO, Y., Gene expression and immunohistochemical localization of basic fibroblast growth factor in renal cell carcinoma. Biochem. biophys. Res. Comm., 183, 937-944 (1992).
6. HOU, J., KAN. M., MCKEEHAN, K., MCBRIDE, G., ADAMS, P. and MCKEEHAN, W.L., Fibroblast growth factor receptors from liver vary in three structural domains. Science (Wash.), 251, 665-668 (1991).
7. IMAMURA, T., TOKITA, Y. and MITEUI, Y., Identification of a heparin-binding growth factor-1 nuclear translocation sequence by deletion mutation analysis. J. biol. Chem., 267, 5676-5679 (1992).
8. JACKSON, A., TARANTINI, F., GAMBLE, S., FRIEDMAN, S. and MACIAG, T., The release of fibroblast growth factor-1 from NIH 3T3 cells in response to temperature involves the function of cysteine residues. J. biol. Chem., 270, 33-36 (1995).
9. JAYE, M., LYALL, R.M., MUDD, R., SCHLESSINGER, J. and SARVER, N., Expression of acidic fibroblast growth factor cDNA confers growth advantage and tumorigenesis to Swiss 3T3 cells. EMBO J., 7, 963-969 (1988).
10. KAN, M., DISORBO, D., HOU, J.Z., HOSHI, H., MANSSON, P.E. and MCKEEHAN, W.L., High and low affinity binding of heparin-binding growth factor to a 130-kDa receptor correlates with stimulation and inhibition of growth of a differentiated human hepatoma cell. J. biol. Chem., 263, 11306-11313 (1988).
11. KUROKAWA, R., KYAKUMOTO, S. and OTA, M., Autocrine growth factor in defined serum-free medium of human salivary gland adenocarcinoma cell line HSG. Cancer Res., 49, 5136-5142 (1989).
12. LOGAN, A., Intracrice regulation of the nucleus - a further mechanism of growth factor activity? J. Endocrinol., 125, 339-343 (1990).
13. MATSUZAKI, K., YOSHITAKE, Y., MATUO, Y., SASAKI, H. and NISHIKAWA, K., Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis. Proc. nat. Acad. Sci (Wash.), 86, 9911-9915 (1989).
14. MCKEEHAN, W.L. and CRABB, J.W., Isolation and characterization of different molecular and Chromatographic forms of heparin-binding growth factor 1 from bovine brain. Anal. Biochem., 164, 563-569 (1987).
15. MIGNATTI, P., MORIMOTO, T. and RIFKIN, D.B., Basic fibroblast growth factor released by single, isolated cells stimulates their migration in an autocrine manner. Proc. nat. Acad. Sci. (Wash.), 88, 11007-11011 (1991).
16. MIKI, T., BOTTARO, D.P., FLEMING, T.P., SMITH, C.L., BURGESS, W.H., CHAS, A.M. and AARONSON, S.A., Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc. nat. Acad. Sci. (Wash.), 89, 246-250 (1992).
17. MORRISON, R.S., Suppression of basic fibroblast growth factor expression by antisense oligodeoxynucleotides inhibits the growth of transformed human astrocytes. J. biol. Chem., 266, 728-734 (1991).
18. MUENKE, M. and SCHELL, U., Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trends Genet., 11, 308-313 (1995).
19. MUTHUKRISHNAN, L., WARDER, E. and MCNEIL, P.L., Basic fibroblast growth factor is efficiently released from a cytosolic storage site through plasma membrane disruptions of endothelial cells. J. cell Phystol., 148, 1-16 (1991).
20. MYOKEN, Y., KAN, M., CHEN, J., MCKEEHAN, W.L., SATO, G.H. and SATO, J.D., Monoclonal antibodies against heparin-binding growth factor-1: neutralization of biological activity and recognition of specific amino acid sequence. Biochem. biophys. Res. Comm., 197, 1450-1457 (1993).
21. MYOKEN, Y., KAYADA, Y., OKAMOTO, T., KAN, M., SATO, G.H. and SATO, J.D., Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites. Proc. nat. Acad. Sci. (Wash.), 88, 5819-5823 (1991).
22. MYOKEN, Y., MYOKEN, Y., OKAMOTO, T., KAN, M., SATO, J.D. and TAKADA, K., Release of fibroblast growth factor-1 by human squamous cell carcinoma correlates with autocrine cell growth. In Vitro cell Devel. Biol., 30, 790-795 (1994a).
23. MYOKEN, Y., MYOKEN, Y., OKAMOTO, T., SATO, J.D., KAN, M , MCKEEHAN, W.L., NAKAHARA, M. and TAKADA, K., Immunohistochemical study of expression of fibroblast growth factor-1 (FGF-1) and FGF-2 and FGF receptor-1 in human malignant salivarv gland tumors J. Pathol. (1996). (In press).
24. MYOKEN, Y., MYOKEN, Y., OKAMOTO, T., SATO, J.D. and TAKADA, K., Immunohistochemical localization of fibroblast growth factor-1 (FGF-1) and FGF-2 in oral squamous cell carcinoma (SCC). J. oral Pathol. Med., 23, 451-456 (1994e).
25. MYOKEN, Y., MYOKEN, Y., OKAMOTO, T., SATO, J.D. and TAKADA, K., Effect of fibroblast growth factor 1 on the three-dimensional growth and morphogenesis on human salivary gland epithelial cells embedded in collagen gels. In Vitro cell. Devel. Biol., 31, 84-86 (1995).
26. OSAKI, T., OKAMOTO, T., YABUMOTO, M., MYOKEN, Y. and TAKADA, K., Effect of epidermal growth factor and fibroblast growth factor on the growth of normal epithelial cells and oral cancer cells in serum-free culture and the expression of growth factor receptor on the cells. Jap. J. oral maxillofac. Surg., 37, 42 (abstr.) (1991).
27. RENKO, M., QUARTO, N., MORIMOTO, T. and RIFKIN, D.B., Nuclear and cytoplasmic localization of different basic fibroblast growth factor species. J. cell. Physiol., 144, 108-114 (1990).
28. RON, D., REICH, R., CHEDID, M., LENGEL, C., COHEN, O.E., CHAN, A.M., NEUFELD, G., MIKI, T. and TRONICK, S.R., Fibroblast growth factor receptor 4 in a high affinity receptor for both acidic and basic fibroblast growth factor but not for keratinocyte growth factor. J. biol. Chem., 268, 5388-5394 (1993).
29. SASADA, R., KUROKAWA, T., IWANE, M. and IGARASHI, K., Transforma-tion of mouse BALB/c 3T3 cells with human basic fibroblast growth factor cDNA. Mol. cell. Biol., 8, 588-594 (1988).
30. SCATCHARD, G., The attractions of proteins for small molecules and ions. Ann. N.Y. Acad. Sci., 51, 660-672 (1949).
31. SPORN, M.B. and ROBERTS, A.B., Autocrine growth factors and cancer. Nature (Lond.), 313, 745-747 (1985).
32. STEFANIK, D.F., RIZKALLA, L.R., SOI, A., GOLDBLATT, S.A. and RIZKALLA, W.M., Acidic and basic fibroblast growth factors are present in glioblastoma multiforme. Cancer Res., 51, 5760-5765 (1991).
33. TANIMOTO, H., YOSHIDA, K., YOKOZAKI, H., YASUI, W., NAKAYAMA, H., ITO, H., OHAMA, K. and TAHARA, E., Expression of basic fibroblast growth factor in human gastric carcinomas. Virchows Arch. B Cell Pathol., 61, 263-267 (1991).
34. WANG, W.P., LEHTOMA, K., VARBAN, M.L., KRISHNAN, I. and CHIU, I.M., Cloning of the gene coding for human class-1 heparin-binding growth factor and its expression in fetal tissues. Mol. cell. Biol., 9, 2387-2395 (1989).
35. YANAGAWA, T., HAYASHI, Y., NAGAMINE, S., YOSHIDA, H., YURA, Y. and SATO, M., Generation of cells with phenotypes of both intercalated duct-type and myoepithelial cells in human parotid gland adenocarcinoma clonal cells grown in athymic nude mice. Virchows Arch. B Cell Pathol., 51, 187-195 (1986).